<DOC>
<DOCNO>EP-0626178</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Use of inhibitors of HIV-protease for the treatment of tumorous diseases.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3805	A61K3805	A61K3807	A61K3807	A61K3855	A61K3855	A61P3500	A61P3500	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61P	A61P	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K38	A61K38	A61K38	A61K38	A61K38	A61K38	A61P35	A61P35	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The present invention relates to the use of inhibitors of HIV aspartate proteases such as HIV-1 or HIV-2 protease, and their salts as well as prodrugs for inhibiting the growth of tumours, especially those tumours which do not respond to inhibition of HIV aspartate proteases themselves, and for the production of pharmaceutical products which are intended to be used for the prophylaxis and, in particular, therapy of tumourous diseases, and to methods and pharmaceutical products for tumour treatment with these compounds.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
CIBA GEIGY AG
</APPLICANT-NAME>
<APPLICANT-NAME>
CIBA-GEIGY AG
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
BOLD GUIDO DR
</INVENTOR-NAME>
<INVENTOR-NAME>
CUMIN FREDERIC DR
</INVENTOR-NAME>
<INVENTOR-NAME>
LANG MARC DR
</INVENTOR-NAME>
<INVENTOR-NAME>
REGENASS URS DR
</INVENTOR-NAME>
<INVENTOR-NAME>
ROESEL JOHANNES DR
</INVENTOR-NAME>
<INVENTOR-NAME>
BOLD, GUIDO, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
CUMIN, FREDERIC, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
LANG, MARC, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
REGENASS, URS DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
ROESEL, JOHANNES, DR.
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
